drugset / Trial / NCT00576342

Patient Preference Study

NCT00576342

Phase 3 Completed 129 enrolled Alcon Research
RandomizedCrossoverTriple-blindTreatment

Summary

In this randomized crossover study, patients will receive a single drop of two test articles and assess comfort.

Timeline

Start
2007-12
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AL-3862 Unknown Other
Subject Dorzolamide Small molecule Other
Background Timolol Other / unclassified Other